Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target

María Garranzo‐Asensio(Universidad Complutense de Madrid), Rodrigo Barderas(Instituto de Salud Carlos III)

Diabetes

January 18, 2022

10.2337/db20-1206

Cited by 14

Related Papers

p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins

|Cancers|2023|23